How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

5,617 results for

Hypertension Management for Specific Emergencies

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Hypertension Canada's 2018 guidelines for the management of hypertension in pregnancy

blockers. *Fetotoxicity of renal system. Butalia et al. 529 Management of Hypertension in Pregnancyexamined the effect of immediate BP lowering on stroke, BP reduction below this threshold of 160/110 mm Hg is considered to play an important role in the prevention of stroke in pregnancy and is recommended. 19,21 Accordingly, severe hypertension is considered an obstetrical emergency from maternal and fetal perspectives, which requires imme- diate in-hospital care and urgent antihypertensive therapy (...) Hypertension Canada's 2018 guidelines for the management of hypertension in pregnancy Guidelines Hypertension Canada’s 2018 Guidelines for the Management of Hypertension in Pregnancy Sonia Butalia, BSc, MD, MSc, a,b,c Francois Audibert, MD, MSc, d Anne-Marie Côt e, MD, MHSc, e Tabassum Firoz, MD, MSc, f Alexander G. Logan, MD, g Laura A. Magee, MD, MSc, h,i William Mundle, MD, j Evelyne Rey, MD, MSc, k Doreen M. Rabi, MD, MSc, a,b,c Stella S. Daskalopoulou, MD, PhD, l and Kara A. Nerenberg, MD

2018 CPG Infobase

2. Hypertension in adults: diagnosis and management

Hypertension in adults: diagnosis and management Hypertension in adults: diagnosis and Hypertension in adults: diagnosis and management management NICE guideline Published: 28 August 2019 www.nice.org.uk/guidance/ng136 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration (...) be inconsistent with complying with those duties. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Hypertension in adults: diagnosis and management (NG136) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 40Contents Contents Overview 4 Who

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

3. Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period

, severe systolic hypertension; severe diastolic hypertension; or both require urgent antihypertensive therapy. Introducing standardized, evidence-based clinical guidelines for the management of patients with preeclampsia and eclampsia has been demonstrated to reduce the incidence of adverse maternal outcomes. Individuals and institutions should have mechanisms in place to initiate the prompt administration of medication when a patient presents with a hypertensive emergency. Treatment with first- line (...) or newborn, and increased intracranial pressure with potential wors- ening of cerebral edema in the woman (21). Once the hypertensive emergency is treated, a complete and detailed evaluation of maternal and fetal well-being is needed with consideration of, among many issues, the need for subsequent pharmacotherapy and the appropri- ate timing of delivery. Box 1. Sample Order Set for Severe Intrapartum or Postpartum Hypertension Initial First-line Management With Immediate-Release Oral Nifedipine* y c

2019 American College of Obstetricians and Gynecologists

4. Hypertension Management for Specific Emergencies

Hypertension Management for Specific Emergencies Hypertension Management for Specific Emergencies Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer (...) Administration 4 Hypertension Management for Specific Emergencies Hypertension Management for Specific Emergencies Aka: Hypertension Management for Specific Emergencies , Hypertensive Crisis , Malignant Hypertension , Severe Hypertension , Hypertensive Emergency , Hypertensive Urgency , Uncontrolled Hypertension , Acute Severe Hypertension-Related Target Organ Injury Findings From Related Chapters II. Definitiion Severe Hypertension: >180/110 mmHg III. Evaluation IV. Precautions Avoid rapidly lowering

2018 FP Notebook

5. Emergency management of adrenal insufficiency in children: advocating for treatment options in outpatient and field settings

Emergency management of adrenal insufficiency in children: advocating for treatment options in outpatient and field settings Miller BS, et al. J Investig Med 2019;0:1–10. doi:10.1136/jim-2019-000999 1 Review Emergency management of adrenal insufficiency in children: advocating for treatment options in outpatient and field settings Bradley S Miller, 1 Sandra P Spencer, 2 Mitchell E Geffner, 3 Evgenia Gourgari, 4 Amit Lahoti, 5 Manmohan K Kamboj, 2 Takara L Stanley, 6 Naveen K Uli, 7 Brandy (...) : Emergency Management of Adrenal Insufficiency in Children: A Clinical Practice Guideline’, Toronto, Ontario, Canada, May 2018. Accepted 7 February 2019 © American Federation for Medical Research 2019. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. Abs TRACT Adrenal insufficiency (AI) remains a significant cause of morbidity and mortality in children with 1 in 200 episodes of adrenal crisis resulting in death. The goal of this working group of the Pediatric Endocrine Society

2019 Pediatric Endocrine Society

6. Critical Issues in the Evaluation and Management of Adult Patients Presenting to the Emergency Department With Acute Headache

Critical Issues in the Evaluation and Management of Adult Patients Presenting to the Emergency Department With Acute Headache 1 1 2 Clinical Policy: Critical Issues in the Evaluation and Management of Adult Patients Presenting to the 3 Emergency Department With Acute Headache 4 Approved by the ACEP Board of Directors, June 26, 2019 5 6 7 From the American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on 8 Acute Headache: 9 10 Steven A. Godwin, MD (...) Liaison, Clinical Policies Committee and Subcommittee on Acute Headache 50 Rhonda R. Whitson, RHIA, Staff Liaison, Clinical Policies Committee 51 52 53 54 2 ABSTRACT 55 56 This clinical policy from the American College of Emergency Physicians addressed key issues in the evaluation 57 and management of adult patients presenting to the emergency department with acute headache. A writing 58 subcommittee conducted a systematic review of the literature to derive evidence-based recommendations to answer 59

2019 American College of Emergency Physicians

7. Choice of therapy for Adults With Hypertension Without Compelling Indications for Specific Agents

Choice of therapy for Adults With Hypertension Without Compelling Indications for Specific Agents III. Choice of therapy for adults with hypertension without compelling indications for specific agents | Hypertension Canada Guidelines Subgroup Members: George K. Dresser, MD PhD; Robert J. Herman, MD; Pavel Hamet, MD PhD; Ellen Burgess, MD; Richard Lewanczuk, MD PhD; Jean C. Grégoire, MD; Steven E. Gryn, MD; Luc Poirier, BPharm MSc Central Review Committee: Stella S. Daskalopoulou, MD MSc DIC PhD (...) -acting calcium channel blocker (CCB) (Grade B). ‘Hypertension without compelling indications’ refers to patients with hypertension but without other identified comorbid conditions (such as diabetes mellitus or heart disease) that represent compelling indications for specific drug therapy. Randomized controlled trials have shown that antihypertensive therapy in these patients can reduce incidence of cardiovascular disease by 20% to 30%, depending on the specific outcome considered . Reduction

2018 Hypertension Canada

8. ESC/ESH Management of Arterial Hypertension

, hypertension remains the major preventable cause of cardiovascular disease (CVD) and all-cause death globally and in our continent. These 2018 ESC/ESH Guidelines for the management of arterial hypertension are designed for adults with hypertension, i.e. aged ≥18 years. The purpose of the review and update of these Guidelines was to evaluate and incorporate new evidence into the Guideline recommendations. The specific aims of these Guidelines were to produce pragmatic recommendations to improve (...) ESC/ESH Management of Arterial Hypertension We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. 2018 ESC/ESH Guidelines for the management of arterial hypertension | European Heart Journal | Oxford Academic Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close search filter search input Article Navigation Close mobile search navigation

Full Text available with Trip Pro

2018 European Society of Cardiology

9. Transjugular Intrahepatic Portosystemic Stent-Shunt (TIPSS) in the management of portal hypertension

Transjugular Intrahepatic Portosystemic Stent-Shunt (TIPSS) in the management of portal hypertension British Society of Gastroenterology Transjugular Intrahepatic Portosystemic Stent-Shunt (TIPSS) in the management of portal hypertension. Contents Guidelines development group 3 Abstract 4 Executive summary of recommendations 4 Research recommendations: 12 Patient summary 14 Introduction 17 Guideline development 17 Assessing the quality of guidelines: The AGREE II instrument 17 History of TIPSS (...) Nurse Practitioner Reviewer Ms Mandy Lomax Patient Representative Co—author (patient summary) Mr Nicholas Roslund Patient Representative Co-author (patient summary) Abstract These guidelines on Transjugular Intrahepatic Portosystemic Stent-Shunt (TIPSS) in the management of portal hypertension have been commissioned by the Clinical Services and Standards Committee (CSSC) of the British Society of Gastroenterology (BSG) under the auspices of the Liver Section of the BSG. The guidelines are new

2019 British Society of Gastroenterology

10. Guidance on the clinical management of anxiety disorders, specifically focusing on diagnosis and treatment strategies

Guidance on the clinical management of anxiety disorders, specifically focusing on diagnosis and treatment strategies Objective: To provide practical clinical guidance for the treatment of adults with panic disorder, social anxiety disorder and generalised anxiety disorder in Australia and New Zealand. Method: Relevant systematic reviews and meta-analyses of clinical trials were identified by searching PsycINFO, Med- line, Embase and Cochrane databases. Additional relevant studies were (...) triggers diagnostically specific fears of negative consequences of the anxiety itself, and triggers related avoidance behav- iours, which can be disabling. Individuals seek to escape from or avoid situations that trigger these anxieties. This strategy reduces anxiety in the short term, but promotes avoidance as a preferred strategy for managing threat and anxiety in the longer term, which results in the considerable disability and distress associated with an anxiety disorder. These self-reinforcing

2018 Royal Australian and New Zealand College of Psychiatrists

11. Prevention & Treatment of Hypertension - Health Behaviour Management

and lack of quality social support increased the risk of coronary artery disease similar to more conventional risk factors such as smoking, dyslipidemia and hypertension. These findings suggest a link between psychosocial factors and atherosclerosis; however, the specific nature of the association is not known, and it still remains unclear exactly what the role of stress management on long-term outcomes related to hypertension morbidity may be . However, while there is no evidence that stress (...) Prevention & Treatment of Hypertension - Health Behaviour Management I. Health Behaviour Management | Hypertension Canada Guidelines Subgroup Members: Simon L. Bacon, PhD; Janusz Kaczorowski, PhD; Luc Trudeau, MD; Swapnil Hiremath, MD MPH; Norman RC. Campbell, MD; Michael Roerecke, PhD; Joanne Arcand, PhD RD Central Review Committee: Stella S. Daskalopoulou, MD MSc DIC PhD (Chair); Kaberi Dasgupta, MD MSc; Kelly B. Zarnke, MD MSc; Kara Nerenberg, MD, MSc; Alexander A. Leung, MD MPH; Kevin C

2018 Hypertension Canada

12. Management of Hypertension (5th Edition)

Management of Hypertension (5th Edition) Ministry of Health Malaysia Academy of Medicine of Malaysia Malaysian Society of Hypertension Management of Hypertension (4 th Edition) CLINICAL PRACTICE GUIDELINES MOH/P/PAK/272.13(GU) ISBN 978-967-12406-0-1STATEMENT OF INTENT This guideline was developed to be a guide for best clinical practice in the management of hypertension. All efforts were made to ensure references quoted were the most current at the time of printing. Specific attempts were made (...) in Hypertension: Recommendations 19 11 Common Causes of Severe Hypertension 21 12 Oral Treatment for Hypertensive Urgencies 22 13 Treatment Options for Hypertensive Emergencies 23 14 NCEP ATP III and IDF Criteria for the Metabolic Syndrome 27 15 Current Guideline for The Management of Blood Pressure in Acute Phase of Ischaemic Stroke and Intracerebral Haemorrhage 33 16 Anti-Hypertensive Drugs Commonly Used in Pregnancy 40xvii Table No Title Page 17 Anti-Hypertensive Drugs for Severe Preeclampsia with Acute

2018 Ministry of Health, Malaysia

13. Management of specific situations in polycythaemia vera and secondary erythrocytosis

Management of specific situations in polycythaemia vera and secondary erythrocytosis A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis - McMullin - 2019 - British Journal of Haematology - Wiley Online Library By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term The full text of this article hosted at iucr.org is unavailable due to technical difficulties. Guideline (...) Open Access A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis A British Society for Haematology Guideline Centre for Medical Education, Queen's University, Belfast, UK MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK Castle Hill Hospital, Hull and East Yorkshire Hospitals NHS Trust, Hull, UK Leeds Teaching Hospitals NHS Trust, Leeds, UK The Royal

Full Text available with Trip Pro

2018 British Committee for Standards in Haematology

14. Poststroke Fatigue: Emerging Evidence and Approaches to Management: A Scientific Statement for Healthcare Professionals From the American Heart Association

Poststroke Fatigue: Emerging Evidence and Approaches to Management: A Scientific Statement for Healthcare Professionals From the American Heart Association Cardiopulmonary Resuscitation in Adults and Children With Mechanical Circulatory Support: A Scientific Statement From the American Heart Association | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019 (...) durability, and limited numbers of organs available for donation. With the number of patients supported by durable MCS systems increasing in the community, so too is the need for emergency care providers to receive specific guidance on how to assess and treat a patient with MCS who is unresponsive or hypotensive. No evidence-based or consensus recommendations currently exist for the evaluation and treatment of cardiovascular emergencies in patients with MCS. Because of the unique characteristics

2017 American Heart Association

15. Hypertension management and renin-angiotensin-aldosterone system blockade in patients with diabetes, nephropathy and/or chronic kidney disease

Hypertension management and renin-angiotensin-aldosterone system blockade in patients with diabetes, nephropathy and/or chronic kidney disease Hypertension management and renin-angiotensin-aldosterone system blockade in patients with diabetes, nephropathy and/or chronic kidney disease Indranil Dasgupta DM FRCP , Debasish Banerjee MD FRCP , Tahseen A Chowdhury MD FRCP , Parijat De MD FRCP , Mona Wahba MA FRCP , Stephen Bain MD FRCP , Andrew Frankel MD FRCP , Damian Fogarty MD FRCP , Ana Pokrajac (...) MD FRCP and Peter Winocour MD FRCP July 2017 Contents Introduction 3 Evidence grades for the recommendations 3 Search strategy 3 1 Hypertension management and renin-angiotensin-aldosterone system blockade in patients with type 1 diabetes 5 Recommendations 6 Audit standards 6 Areas that require further research 7 Introduction 7 Hypertension in patients with type 1 diabetes 8 Modulation of the RAAS in patients with type 1 diabetes 9 2 Hypertension management and renin-angiotensin-aldosterone system

2017 Association of British Clinical Diabetologists

16. Pharmacological Management of Hypertension

Pharmacological Management of Hypertension Pharmacological Management of Hypertension | National Guideline Clearinghouse success fail JUL Aug 12 2017 2018 2019 02 Oct 2017 - 13 Jul 2018 COLLECTED BY Organization: Formed in 2009, the Archive Team (not to be confused with the archive.org Archive-It Team) is a rogue archivist collective dedicated to saving copies of rapidly dying or deleted websites for the sake of history and digital heritage. The group is 100% composed of volunteers (...) * Remember Me Don't have an account? The AHRQ National Guideline Clearinghouse (NGC, guideline.gov) Web site will not be available after July 16, 2018 because federal funding through AHRQ will no longer be available to support the NGC as of that date. For additional information, read our . Guideline Synthesis Pharmacological Management of Hypertension Guidelines Being Compared: American College of Physicians (ACP) Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus

2017 National Guideline Clearinghouse (partial archive)

17. Guideline for the diagnosis and management of hypertension in adults — 2016

Guideline for the diagnosis and management of hypertension in adults — 2016 Guideline for the diagnosis and management of hypertension in adults — 2016 | The Medical Journal of Australia mja-search search Use the for more specific terms. Title contains Body contains Date range from Date range to Article type Author's surname Volume First page doi: 10.5694/mja__.______ Search Reset  close Individual Login Purchase options Connect person_outline Login keyboard_arrow_down Individual Login (...) causes for hypertension.Few drug therapies specifically target resistant hypertension. Renal denervation is currently being investigated as a treatment option in this condition; however, to date, it has not been found to be effective in the most rigorous study conducted. Optimal medical management (with a focus on treatment adherence and excluding secondary causes) is recommended (grade: strong; level: II). Percutaneous transluminal radiofrequency sympathetic denervation of the renal artery

2016 MJA Clinical Guidelines

18. Emergency Management of Pediatric Pulmonary Hypertension. (PubMed)

Emergency Management of Pediatric Pulmonary Hypertension. Pulmonary hypertension (PH) does not refer to a specific disease but rather a clinical manifestation emanating from a decrease in functional pulmonary vasculature resulting in progressively elevated right ventricle pressure and ultimately right heart failure. It is an uncommon disease process, but because of advancements in treatment, improved survival, and increasing prevalence, there is a greater likelihood that the emergency clinician (...) will have to care for a child with PH. This review article, intended for emergency medical providers for children, is aimed at familiarizing clinicians with pediatric PH including the pathophysiology, clinical presentation and initial diagnostic strategies, basic chronic management, and management of a pulmonary hypertensive crisis.

2016 Pediatric Emergency Care

19. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association

of overweight and obesity 6 in the general population and in patients with increased cardiovascular risk, and a recent report from the Eighth Joint Na- tional Committee addressed the management of hypertension. 7 However, these guidelines did not specifically address the management of such comorbidities in patients with HF. Similarly, the most recent ACCF/AHA HF practice guidelines 8 in 2013 addressed the overall management of comorbidities in patients with HF in broad terms, but again, specific (...) Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association Circulation. 2016;134:e535–e578. DOI: 10.1161/CIR.0000000000000450 December 6, 2016 e535 CLINICAL STATEMENTS AND GUIDELINES T he comorbidities of hypertension, diabetes mellitus, obesity, hyperlipidemia, and metabolic syndrome are common in patients with heart failure (HF

Full Text available with Trip Pro

2016 American Heart Association

20. Hypertension Management for Specific Populations

Hypertension Management for Specific Populations Hypertension Management for Specific Populations Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer (...) Administration 4 Hypertension Management for Specific Populations Hypertension Management for Specific Populations Aka: Hypertension Management for Specific Populations , Antihypertensives for Specific Populations From Related Chapters II. Approach: Young Hypertensive Pathophysiology Active Increased sympathetic tone Elevated Plasma Activity (PRA) First choice medications or Other medications Beta-alpha antagonist Alpha-1 antagonist Avoid s Decreased HDL Sexual activity and affected III. Approach: Athletes

2018 FP Notebook

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>